Drug Warehouse Inspections Kommentar [rj1]: Where is your

summary?
In February 2012, Brian Bilbray wrote HR 4056, a bill that would prevent states from conducting
duplicative inspections of drug warehouses and medical device warehouses conducted by the
FDA. [Thomas.loc.gov, 2/16/12]

The bill would benefit life science companies and help them get their product to market faster.
[North County Times, 2/22/12] Kommentar [rj2]: Need a link

Companies Lobbying for Bill

Below is a list of companies that lobbied for the bill.

Client Lobbying Firm Amount Spent First Report Most

Containing Bill Recent/Final
Report
Containing Bill
Advanced Advanced $937,755 6/30/12 6/30/12
Medical Medical
Technology Assn Technology Assn
Boston Scientific Boston Scientific $730,000 3/31/12 6/30/12
Corp Corp
Consumers Consumers $80,000 3/31/12 N/A
Union of the US Union of the US
Exxon Mobil Exxon Mobil $4,170,000 3/31/12 N/A
[Lobbying Disclosure Database, accessed 9/21/12]

Bilbray Took $15,000 from PACs Lobbying for the Bill Kommentar [rj3]: Is this just for 2012?
How does this compare to money he
previously took.
Company Amount Date
Advanced Medical Technology Association PAC $1,000 3/29/11
Advanced Medical Technology Association PAC $1,000 6/07/12
Boston Scientific Corporation PAC $1,000 3/07/11
Boston Scientific Corporation PAC $1,000 4/17/12
Boston Scientific Corporation PAC $1,000 6/13/12
Exxon Mobil Corporation PAC $5,000 7/24/12
Exxon Mobil Corporation PAC $5,000 2/17/12 Kommentar [rj4]: One day later
TOTAL $15,000
[CQ Money Line, accessed 9/21/12]

Bilbray received $15,000 from companies that lobbied on the bill this cycle. Of the
$15,000, $13,000 was donated 5 months after Bilbray introduced the bill.

This cycle, Bilbray took $124,750 from the pharmaceutical industry. [opensecrets.org,
accessed 9/21/12]

Took $37,500 from Companies Benefitting from Bill

During the 2012 cycle, Bilbray took $37,500 from companies who stood to benefit from the bill. Kommentar [rj5]: What about previous
cycles? Does this figure include employees
[opensecrets.org, accessed 9/24/12] of these companies, or is it just the PACs?

Company Individuals PAC Total

Millennium Laboratories $17,500 $0 $17,500
Abbott Laboratories $0 $10,000 $10,000
Life Technologies Corp $10,000 $0 $10,000
TOTAL $27,500 $10,000 $37,500